Salvatore Novello

Affiliations: 
EPFL - Brain Mind Institute, Lausanne, Vaud, Switzerland 
Area:
Neurodegeneration, Parkinson's Disease, Protein aggregation, LRRK2, Microdialysis
Google:
"Salvatore Novello"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Teixidor J, Novello S, Ortiz D, et al. (2022) On-Demand Nanoliter Sampling Probe for the Collection of Brain Fluid. Analytical Chemistry
Domenicale C, Mercatelli D, Albanese F, et al. (2022) Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines. 10
Novello S, Mercatelli D, Albanese F, et al. (2022) In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162: 105579
Sarti AC, Vultaggio-Poma V, Falzoni S, et al. (2021) Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance. Function (Oxford, England). 2: zqab005
Lashuel HA, Novello S. (2021) Lewy body-associated proteins: Victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein. Neurobiology of Disease. 105417
Regoni M, Zanetti L, Comai S, et al. (2021) Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse Biomedicines
Regoni M, Zanetti L, Comai S, et al. (2021) Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines. 9
Regoni M, Cattaneo S, Mercatelli D, et al. (2020) Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell Death & Disease. 11: 963
Bourdenx M, Nioche A, Dovero S, et al. (2020) Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates. Science Advances. 6: eaaz9165
Pisanò CA, Brugnoli A, Novello S, et al. (2020) Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease. Neuropharmacology. 167: 108006
See more...